Alps Advisors Inc. increased its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 7.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 214,630 shares of the technology company's stock after purchasing an additional 15,430 shares during the quarter. Alps Advisors Inc. owned approximately 0.19% of Amdocs worth $19,639,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. Farther Finance Advisors LLC lifted its holdings in shares of Amdocs by 17.5% during the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after buying an additional 147 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Amdocs by 7.8% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,738 shares of the technology company's stock valued at $616,000 after buying an additional 490 shares during the last quarter. HighTower Advisors LLC lifted its holdings in shares of Amdocs by 20.0% during the 4th quarter. HighTower Advisors LLC now owns 15,374 shares of the technology company's stock valued at $1,309,000 after buying an additional 2,561 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Amdocs by 55.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after buying an additional 208 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Amdocs by 16.1% during the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock valued at $261,756,000 after buying an additional 426,035 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the company. Wolfe Research assumed coverage on Amdocs in a report on Tuesday. They set an "outperform" rating for the company. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday, June 7th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Amdocs presently has a consensus rating of "Buy" and an average price target of $105.33.
Get Our Latest Stock Report on DOX
Amdocs Stock Performance
Shares of DOX stock traded down $0.98 during trading on Friday, reaching $88.26. The company had a trading volume of 965,017 shares, compared to its average volume of 663,955. The firm's 50 day simple moving average is $91.63 and its two-hundred day simple moving average is $88.32. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41. The company has a market capitalization of $9.96 billion, a PE ratio of 18.58, a PEG ratio of 1.47 and a beta of 0.52.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, topping the consensus estimate of $1.71 by $0.07. The company had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a return on equity of 19.52% and a net margin of 11.39%. The company's revenue for the quarter was down 9.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.56 EPS. Sell-side analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be given a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date is Monday, June 30th. Amdocs's dividend payout ratio is presently 44.42%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.